Maintenance of tumor initiating cells of defined genetic composition by nucleostemin
about
Telomerase reverse transcriptase regulates microRNAsInvolvement of telomerase reverse transcriptase in heterochromatin maintenanceTelomeres, NAFLD and Chronic Liver DiseaseTelomerase reverse transcriptase moonlights: Therapeutic targets beyond telomeraseImplications of telomere-independent activities of telomerase reverse transcriptase in human cancerFulvestrant induces resistance by modulating GPER and CDK6 expression: implication of methyltransferases, deacetylases and the hSWI/SNF chromatin remodelling complexDissecting the expression landscape of RNA-binding proteins in human cancersForced expression of Nanog or Esrrb preserves the ESC status in the absence of nucleostemin expressionTelomerase reverse transcriptase in the regulation of gene expression.Essential role of the cancer stem/progenitor cell marker nucleostemin for indole-3-carbinol anti-proliferative responsiveness in human breast cancer cells.Eribulin mesylate targets human telomerase reverse transcriptase in ovarian cancer cells.Nucleostemin expression in invasive breast cancer.FAK activity protects nucleostemin in facilitating breast cancer spheroid and tumor growthTelomerase and retrotransposons: reverse transcriptases that shaped genomesTelomere-independent functions of telomerase in nuclei, cytoplasm, and mitochondriaDe Novo RNA Synthesis by RNA-Dependent RNA Polymerase Activity of Telomerase Reverse TranscriptaseThe role of telomeres and telomerase reverse transcriptase isoforms in pluripotency induction and maintenanceAntagonistic roles of Drosophila Tctp and Brahma in chromatin remodelling and stabilizing repeated sequences.An investigation of the effects of the core protein telomerase reverse transcriptase on Wnt signaling in breast cancer cells.High OCT4A levels drive tumorigenicity and metastatic potential of medulloblastoma cells.Structure-function relationship and biogenesis regulation of the human telomerase holoenzyme.Genetic Interactions of STAT3 and Anticancer Drug Development.Transcriptional outcome of telomere signalling.Emerging roles of nucleolar and ribosomal proteins in cancer, development, and aging.Upregulation of GNL3 expression promotes colon cancer cell proliferation, migration, invasion and epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.Leucine Zipper Down-regulated in Cancer-1 (LDOC1) interacts with Guanine nucleotide binding protein-like 3-like (GNL3L) to modulate Nuclear Factor-kappa B (NF-κB) signaling during cell proliferation.GNL3 and SKA3 are novel prostate cancer metastasis susceptibility genes.Telomerase reverse transcriptase expression protects transformed human cells against DNA-damaging agents, and increases tolerance to chromosomal instability.Telomerase stimulates ribosomal DNA transcription under hyperproliferative conditions.Concomitant upregulation of nucleostemin and downregulation of Sox2 and Klf4 in gastric adenocarcinoma.Nucleostemin knocking-down causes cell cycle arrest and apoptosis in human T-cell acute lymphoblastic leukemia MOLT-4 cells via p53 and p21Waf1/Cip1 up-regulation.Nucleostemin and TWIST as predictive markers for recurrence after neoadjuvant chemotherapy for esophageal carcinoma.Discovering the miR-26a-5p Targetome in Prostate Cancer Cells.Overexpression of nucleostemin contributes to an advanced malignant phenotype and a poor prognosis in oral squamous cell carcinoma.Identification of XBP1-u as a novel regulator of the MDM2/p53 axis using an shRNA library.Tandem affinity purification of AtTERT reveals putative interaction partners of plant telomerase in vivo.A literature mining-based approach for identification of cellular pathways associated with chemoresistance in cancer.ATF7 mediates TNF-α-induced telomere shortening.Stem cell self-renewal factors Bmi1 and HMGA2 in head and neck squamous cell carcinoma: clues for diagnosis.Cells with stemness features are generated from in vitro transformed human fibroblasts
P2860
Q24313154-3B3C20BD-F8A1-4ADC-A2D6-4987A3F7A44AQ24337650-5C0E6C70-177E-47BC-8B9A-A76145807887Q26753037-9B64B04C-A24B-463A-95A7-E6161335A7F3Q26786613-CB90C934-AF02-4DAF-BED2-96E99666DD97Q26825812-831168AE-8F9B-4DEC-9646-616E2D0FC513Q28301066-35421A34-7A6C-44DA-BA35-87536DD493F8Q28305624-296C8F07-40F2-4CE5-8B22-628AA117A339Q29465793-770F268E-A00C-4078-A8BA-989AFF0D4F2EQ34179834-FB40B342-6903-48A8-814A-7A3F4D212655Q34270803-CB4B1ED8-2295-4DF3-BBDD-3154216C670DQ34466428-4D453007-8AFD-42F9-A68E-18B4D63356C8Q35125899-5BF28AEC-B225-41E2-AB57-A10B33014CE4Q35532179-C5DA8C0C-F24F-448F-A949-1BDFDB953241Q35651418-E0E5B24E-36F3-4129-BA57-7EA2F90DA7FFQ36285737-0BB79D01-6CE7-43ED-A222-26AAB559F275Q36811739-6D44B168-D120-4F0A-BF9B-DEA2AC998E14Q37194184-8D4A68E3-C498-45E6-B1E8-6F4E4077910CQ37324135-AFC39885-9FDC-42F0-ADFD-A78B3B6D4799Q37546085-FCD58DE6-581E-4287-AF19-C19905175AF5Q37745955-7FEDF217-053D-4764-A20F-5CB53CBD1B1CQ38095606-F0476AB5-06FB-4024-AF4B-F0FB48A83FA6Q38198930-BD71729F-5707-4148-BC26-A0020FD14D26Q38218964-0D701EFD-9D73-4E79-ACE3-B9453DDF4241Q38553237-09B36C01-977C-4A37-92C9-04A1F48601D6Q38604538-1C25BA86-087A-4620-84DF-6698A30F0AD6Q38739496-6CACAB9C-1152-4DAF-B5BB-003E76162617Q38830853-68E57EE1-37A2-4BB2-A396-5230AA825183Q38884691-9ECE13AC-640C-4AD0-8D07-A73C745315BDQ38966600-3B54B806-2321-4F52-926F-73B7BE5D5E11Q39001358-16252004-038E-4868-A02C-800EB364839CQ39015645-7E7D8514-ED40-410C-8D02-8F63CE4CE027Q39448696-2F8C9BA8-C2B5-42A4-BC4E-1AE9D74BEAF4Q41721802-759F878F-317B-46A6-8652-2D6B3D2B11D9Q42108013-A6756416-7540-4875-B03C-F58AFE4BA4EFQ43064484-61FA62D3-76FE-4F43-BA01-F927E6E2491BQ50476577-6CD2202F-0EF0-4083-9B8E-6DE0E488EB62Q50875340-61FCFD06-1A85-437B-A0C1-CF514B9F5DD8Q51766693-6DC80154-474F-4724-BC9D-FF2EE0CF3AD3Q54718382-4DD06263-26A9-48D0-8A69-4A5DDC70C632Q58740672-55DEE82F-E441-43EA-88A1-EB8FDE908854
P2860
Maintenance of tumor initiating cells of defined genetic composition by nucleostemin
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Maintenance of tumor initiating cells of defined genetic composition by nucleostemin
@ast
Maintenance of tumor initiating cells of defined genetic composition by nucleostemin
@en
type
label
Maintenance of tumor initiating cells of defined genetic composition by nucleostemin
@ast
Maintenance of tumor initiating cells of defined genetic composition by nucleostemin
@en
prefLabel
Maintenance of tumor initiating cells of defined genetic composition by nucleostemin
@ast
Maintenance of tumor initiating cells of defined genetic composition by nucleostemin
@en
P2093
P2860
P356
P1476
Maintenance of tumor initiating cells of defined genetic composition by nucleostemin
@en
P2093
Christine Nguyen
Keith L Ligon
Kenkichi Masutomi
Kiyoko Fukami
Mami Yasukawa
Naoko Okamoto
Richard Possemato
Tatsuhiro Shibata
William C Hahn
Yoshiko Maida
P2860
P304
20388-20393
P356
10.1073/PNAS.1015171108
P407
P50
P577
2011-07-05T00:00:00Z